Convalescent Plasma Therapy and COVID-19: A Scientometric Analysis

Abstract

Call to action condition during COVID-19 epidemic outbreak, where no specific antiviral agents were available to treat, convalescent plasma transfusion was used worldwide to prevent severity and disease progression. Since the late 19th century, convalescent plasma therapy was used worldwide to weaken several outbreaks caused by human respiratory viruses like 1918 Spanish flu pandemic, 1958 Argentine hemorrhagic fever in Argentina, 2003 SARS epidemic (SARS-CoV-1), and 2019 COVID-19 pandemic. This scientometric analysis focuses on the research done on CP therapy and COVID-19 during 2019 to 2022 to know the most productive authors with their affiliation, keyword analysis and highly cited publications to get overview of research progress. A total of 1,56,071 publications was found in Web of Science for the years 2019 to 2022. VoSViewer and Bibliometrix R were used for data analysis. Harvard Medical School having highest publications. USA, China, UK, Italy, India, Germany, Canada, Australia, Iran and France are the top 10 contributing countries. Purpose: COVID-19 virus outbreak all over the world. An increasing number of researches for the use of CP therapy in COVID-19 patients are upcoming research and this report aims at performing scientometric analysis of all the available researches to get the detailed analysis.